Your browser doesn't support javascript.
loading
Cancer killers in the human gut microbiota: diverse phylogeny and broad spectra.
Zhou, Yu-Jie; Zhao, Dan-Dan; Liu, Huidi; Chen, Hao-Ting; Li, Jia-Jing; Mu, Xiao-Qin; Liu, Zheng; Li, Xia; Tang, Le; Zhao, Zhan-Yi; Wu, Ji-Heng; Cai, Yu-Xuan; Huang, Ya-Zhuo; Wang, Peng-Ge; Jia, Yi-Yue; Liang, Pei-Qiang; Peng, Xue; Chen, Si-Yu; Yue, Zhi-Lin; Yuan, Xin-Yuan; Lu, Tammy; Yao, Bing-Qing; Li, Yong-Guo; Liu, Gui-Rong; Liu, Shu-Lin.
Afiliação
  • Zhou YJ; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Zhao DD; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Liu H; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Chen HT; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Li JJ; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Mu XQ; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Liu Z; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Li X; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Tang L; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Zhao ZY; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Wu JH; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Cai YX; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Huang YZ; Colorectal Surgery Department, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Wang PG; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Jia YY; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Liang PQ; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Peng X; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Chen SY; Current affiliation: Department of Ecosystems and Public Health, University of Calgary, Calgary, Canada.
  • Yue ZL; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Yuan XY; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Lu T; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Yao BQ; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Li YG; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
  • Liu GR; HMU-UCFM Centre for Infection and Genomics, Harbin Medical University, Harbin, China.
  • Liu SL; Systemomics Center, College of Pharmacy, and Genomics Research Center, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, China.
Oncotarget ; 8(30): 49574-49591, 2017 Jul 25.
Article em En | MEDLINE | ID: mdl-28484095
Cancer as a large group of complex diseases is believed to result from the interactions of numerous genetic and environmental factors but may develop in people without any known genetic or environmental risks, suggesting the existence of other powerful factors to influence the carcinogenesis process. Much attention has been focused recently on particular members of the intestinal microbiota for their potential roles in promoting carcinogenesis. Here we report the identification and characterization of intestinal bacteria that exhibited potent anti-malignancy activities on a broad range of solid cancers and leukemia. We collected fecal specimens from healthy individuals of different age groups (preschool children and university students), inspected their effects on cancer cells, and obtained bacteria with potent anti-malignancy activities. The bacteria mostly belonged to Actinobacteria but also included lineages of other phyla such as Proteobacteria and Firmicutes. In animal cancer models, sterile culture supernatant from the bacteria highly effectively inhibited tumor growth. Remarkably, intra-tumor administration of the bacterial products prevented metastasis and even cleared cancer cells at remote locations from the tumor site. This work demonstrates the prevalent existence of potent malignancy-killers in the human intestinal microbiota, which may routinely clear malignant cells from the body before they form cancers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Neoplasias Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Neoplasias Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos